Delivery Order SPE2DB25D9348-SPE2DB25FNMNH

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,807.43 contract is for the delivery of 4,563,469,393 units of the prescription drug Jakafi 25 mg tablets. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,565,106,523 units of the prescription drug Jakafi 15 mg tablet. This order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,999.80 contract is for the delivery of 60 tablets of the prescription drug Jakafi 15 mg by February 4, 2025. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $80,134.32 contract is for the delivery of 4,557,399,314 units of Jakafi 5 mg tablets. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery orders...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization. The $47,399.24 contract provides the DLA with Jakafi 5 mg tablets over a period ending on April 4, 2024. This delivery order is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group to supply a broad range of pharmaceutical products to military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $47,362.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,373 units of the branded prescription drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which provides a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $94,761.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through March 11, 2024, is for the delivery of 4,563,904,762 units of the pharmaceutical drug Jakafi 5 mg tablets. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $48,462.60, is for the delivery of 4,567,138,190 units of the prescription drug Jakafi 10 mg tablets. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,999.80 contract is for the supply of 60 tablets of the prescription drug Jakafi 15 mg. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,699.62 firm fixed-price contract is for the delivery of the drug Jakafi 5 mg tablets. The contract has a period of performance through May 10, 2024. This award is made under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
  • SPE2DB25D9348
    Indefinite Delivery Contract
  • SPE2DB25D9348-SPE2DB25FNMNH
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,540.30 contract covers the delivery of 4,566,363,307 units of the prescription drug Jakafi 5 mg tablets. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories.

Generated 2/5/25, 9:12 AM